| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.7M | -30.7% |
| Cost of Revenue | $13.6M | -41.8% |
| Gross Profit | $18.2M | +1.6% |
| R&D Expense | $703K | -62.6% |
| SG&A Expense | $11.0M | -19.7% |
| Operating Income | -$3.6M | +74.2% |
| Pre-tax Income | -$5.8M | +62.1% |
| Income Tax | $29K | +104.3% |
| Net Income | -$22.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.8M | +57.6% |
| Accounts Receivable | $5.0M | -18.3% |
| Inventory | $1.2M | -31.5% |
| Current Assets | $12.2M | -0.1% |
| Total Assets | $16.0M | -58.4% |
| Current Liabilities | $14.3M | -8.9% |
| Long-term Debt | $1.8M | -42.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.7M | +11.8% |
| Capital Expenditures | $322K | -9.0% |
| Investing Cash Flow | $6.2M | +2070.2% |
| Financing Cash Flow | $3.0M | -66.6% |
| Free Cash Flow | -$8.0M | +11.7% |
| -46.9% |
| EPS (Basic) | -$5.18 | -43.5% |
| Total Liabilities |
| $32.5M |
| -5.2% |
| Stockholders' Equity | -$63.1M | -48.7% |